ARCHIVES

No Evidence Of Fraud Found In NCI Audit Of NSABP Trials

This article is from The Cancer Letter archive.

Vol. 20 No. 17 | April 29, 1994

Download PDF Visit The Full Archive

Related Articles

FDA Clears Avastin-Interferon Combination In Renal Cancer; Interferon Role Undefined.

August 7, 2009

Academies Updates Guidelines on Stem Cell Research. NIH Begins New T-R01 Program.

September 19, 2008

NIH Offers Curriculum Supplements For K-12

November 5, 1999

Toxicology Program Board To Review Nine Substances.

January 14, 2000

Roger Bonus Bill Wouldn’t Keep Rauscher

May 28, 1976

FDA says green tea unlikely to prevent cancer.

July 8, 2005